US Broker Ratings

Arcellx, Inc. (ACLX) Stock Analysis: High Potential Upside with Strong Buy Ratings

Arcellx, Inc. (ACLX), a pioneering biotechnology company, is garnering significant attention in the healthcare sector for its innovative approach to immunotherapy. The company, headquartered in Redwood City, California, is focused..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 67.54% Potential Upside in the Medical Devices Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a promising player in the healthcare sector, is gaining investor attention due to its groundbreaking contributions to the medical devices industry. Specializing in surgical robotics,..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 52.69% Potential Upside for Investors

Perrigo Company plc (PRGO), a cornerstone in the healthcare sector, offers a comprehensive suite of over-the-counter health and wellness products across various international markets. Headquartered in Dublin, Ireland, this pharmaceutical..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 51% Upside Potential

Inspire Medical Systems, Inc. (NYSE: INSP), a key player in the medical devices sector, has carved out a niche in the healthcare industry with its innovative approach to treating obstructive..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring Growth Potential with a 6.9% Upside

iRhythm Technologies, Inc. (IRTC), a pivotal player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to cardiac monitoring. With a market capitalization..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Poised for a 29.89% Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a notable player in the healthcare sector, is capturing investor attention with its diverse portfolio of over-the-counter (OTC) health and personal care products. Headquartered..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 37.35% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, the company specializes in providing..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 4.15% Upside in the Biotech Sector

In the intricate landscape of biotechnology investments, Akero Therapeutics, Inc. (NASDAQ: AKRO) stands out as a compelling player. With a market capitalization of $4.31 billion, this South San Francisco-based firm..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potential Amid Industry Challenges

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Wilmington, Massachusetts, this established company has..

Vaxcyte, Inc. (PCVX) Investor Outlook: Unpacking a 132% Potential Upside in the Biotech Space

For investors with an interest in the burgeoning field of biotechnology, Vaxcyte, Inc. (PCVX) presents a compelling opportunity. With a current market capitalization of $5.48 billion, Vaxcyte operates within the..

BrightSpring Health Services (BTSG) Stock Report: Analyst Consensus and Growth Potential

BrightSpring Health Services, Inc. (BTSG) is emerging as a noteworthy player in the Healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $6.03 billion, this..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth with a 2.13% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a prominent player in the global pharmaceutical landscape, hailing from India and making significant strides in the Healthcare sector, particularly within the..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 85% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a potential upside of 85.42%, as analysts set their sights on a promising future for this innovative healthcare player. Operating..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Evaluating Its Potential Amidst a $7.86 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a key player in the healthcare sector, has been making waves with its focus on Traditional Chinese Medicine (TCM) for the treatment of neurocognitive..

Cytokinetics, Incorporated (CYTK): Analyst Ratings Show 31% Potential Upside for Biotechnology Innovator

Cytokinetics, Incorporated (NASDAQ: CYTK) has been making waves in the biotechnology sector with its focus on developing muscle activators and inhibitors for treating debilitating diseases. With a market capitalization of..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 36% Potential Upside with Solid Analyst Ratings

Investors seeking opportunities within the healthcare sector’s medical instruments and supplies industry may find AptarGroup, Inc. (NYSE: ATR) an intriguing prospect. With a market capitalization of $8.49 billion, this U.S.-based..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Diagnostic Frontier with 30.9% Revenue Growth

Guardant Health, Inc. (NASDAQ: GH), a key player in the diagnostics and research industry, has been making waves with its innovative contributions to precision oncology. With a market capitalization of..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Path with -35.85% Potential Downside

Oscar Health, Inc. (NYSE: OSCR) continues to capture the attention of investors navigating the volatile healthcare sector. As a healthcare technology company based in New York, Oscar Health is known..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 28.81% Potential Upside for Savvy Investors

Investors keen on tapping into the healthcare sector’s promising growth may find Grifols, S.A. (GRFS) an intriguing prospect. With its roots firmly planted in the drug manufacturing industry, this Spanish..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Robust Growth Trajectory with 8.52% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its innovative approach to organ transplant therapy. The company’s unique Organ Care System (OCS) is setting new..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds